Laparoscopic total gastrectomy for adenocarcinoma is a widely diffused operation in eastern countries, but there are only a few reports from western centers. We assessed a single surgeon's experience at a single, nonacademic, community hospital.
Methods
Short-term outcome of patients undergoing laparoscopic total gastrectomy for adenocarcinoma (June 2005-March 2010) was assessed.
Results
Fourteen patients (5 males, 9 females; median age, 66.8 years [interquartile range, 59.7–71.8]) underwent laparoscopic total gastrectomy. The median operative time was 240 min. There were five stage 1 patients, five stage 2, and four stage 3; R0 resection was obtained in all 14 patients, and the median number of lymph nodes retrieved was 38. Mortality and overall morbidity rates were 0% and 35.7%, respectively.
Conclusions
The outcomes of laparoscopic total gastrectomy for adenocarcinoma performed by a well-trained laparoscopic surgeon working in a community hospital are good in terms of safety for the patients and response to the oncological criteria used in open surgery.
AzagraJ.S., GeorgenM., De SimoneP., Ibanez-AguireJ.L.: Minimally invasive surgery for gastric cancer.Surg Endosc, 13: 351–357, 1999.
2.
AdachiY., ShiraishiN., ShiromizuA., BandohT., AramakiM., KitanoS.: Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy.Arch Surg, 135: 806–810, 2000.
3.
HuscherC.G., MingoliA., SgarziniG., SansonettiA., DiPaolaM., RecherA., PonzanoC.: Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial.Ann Surg, 241: 232–237, 2005.
4.
WeberK.J., ReyesC.D., GagnerM., DivinoC.M.: Comparison of laparoscopic and open gastrectomy for malignant disease.Surg Endosc, 17: 968–971, 2003.
5.
TopalB., LeysE., EctorsN., AertsR., PenninckxF.: Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma.Surg Endosc, 22: 980–984, 2008.
6.
SarelaA.I.: Entirely laparoscopic radical gastrectomy for adenocarcinoma: lymph node yield and resection margins.Surg Endosc, 23: 153–160, 2009.
7.
DulucqJ.L., WintringerP., StabiliniC., SolinasL., PerissatJ., MahajnaA.: Laparoscopic and open gastric resections for malignant lesions: a prospective, comparative study.Surg Endosc, 19: 933–938, 2005.
8.
HuscherC.G., MingoliA., SgarziniG., BrachiniG., BindaB., Di PaolaM., PonzanoC.: Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series.Am J Surg, 194: 839–844, 2007.
9.
PuglieseR., MaggioniD., SansonnaF., ScandroglioI., FerrariG.C., Di LerniaS., CostanziA., PaunaJ., de MartiniP.: Total and subtotal laparoscopic gastrectomy for adenocarcinoma.Surg Endosc, 21: 21–27, 2007.
10.
CarboniF., LepianeP., SantoroR., ManciniP., Lo RussoR., SantoroE.: Laparoscopic surgery for gastric cancer: preliminary experience.Gastric Cancer, 8: 75–77, 2005.
11.
VarelaJ.E., HiyashiM., NguyenT., SabioA., WilsonS.E., NguyenN.T.: Comparison of laparoscopic and open gastrectomy for gastric cancer.Am J Surg, 192: 837–842, 2006.
12.
MaruyamaK., KaminishiM., HayashiK., IsobeY., HondaI., KataiH., AraiK., KoderaY., NashimotoA.: Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry.Gastric Cancer, 9: 51–66, 2006.
13.
BrownJ.J., DevesaS.S.: Epidemiologic trends in esophageal and gastric cancer in the United States.Surg Oncol Clin N Am, 11: 235–256, 2002.
14.
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM, MRC CLASSIC trial group:Short-term endopoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomized controlled trial.Lancet, 365: 1718–1726, 2005.
15.
The Clinical Outcomes of Surgical Therapy Study Group:A comparison of laparoscopically assisted and open colectomy for colon cancer.N Engl J Med, 350: 2050–2059, 2004.
16.
Bonenkamp JJ; Hermans J, Sasako M, van deVelde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Dutch Gastric Cancer Group:Extended lymph node dissection for gastric cancer.N Engl J Med, 340: 908–914, 1999.
17.
CuschieriA., FayersP., FieldingJ., CravenJ., BancewiczJ., JoypaulV., CookP.: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial.The Surgical Cooperative Group: Lancet, 347: 995–999, 1996.
18.
WuC.W., HsiungC.A., LoS.S., HsiehM.C., ChenJ.H., LiA.F., LuiW.Y., Whang-PengJ.: Nodal dissection for patients with gastric cancer. A randomised controlled trial.Lancet Oncol, 7: 309–315, 2006.
19.
De BreeE., CharalampakisV., MelissasJ., TsiftsisD.: The extent of lymph node dissection for gastric cancer: a critical appraisal.J Surg Oncol, 102: 552–562, 2010.
20.
CsendesA., BurdilesP., RojasJ., BraghettoI., DiazJ.C., MaluendaF.: A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma.Surgery, 131: 401–407, 2002.
21.
YuW., ChoiG.S., ChungH.Y.: Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer.Br J Surg, 93: 559–563, 2006.
